to-BBB is a clinical stage biotechnology company focusing on enhanced drug delivery across the blood-brain barrier. The company is developing novel treatments for devastating brain disorders, such as brain cancer, neurodegenerative diseases and lysosomal storage diseases, by combining existing...

Read more

Meet us at

MS Boston 2014

» 10 September 2014

ESMO - Madrid

» 26 September 2014

Biotech in Europe Forum - Basel

» 30 September 2014